Tamoxifen Citrate Tablet
Product Images NDC 0591-2473

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tamoxifen Citrate (NDC 0591-2473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Tamoxifen Citrate showing its molecular framework with aromatic rings, ethyl group, and functional groups consistent with the molecule's formula (C32H37NO8). The diagram includes annotations of specific molecular fragments.*

FDA Label Image

Image 2

Tamoxifen Citrate Tablets USP 10 mg oral tablets label from Actavis Pharma, Inc., showing a unit-of-use package with 60 tablets. Includes dosage strength, instructions to dispense medication guide, storage conditions, warnings to keep out of reach of children, and manufacturer information for Teva Pharmaceuticals.*

FDA Label Image

Image 3

Tamoxifen Citrate Tablets, USP 20 mg oral tablets label shows the NDC 0591-2473-30 and contains 30 tablets unit-of-use. The label includes usage instructions, storage conditions, and a barcode. Manufactured for Teva Pharmaceuticals, Parsippany, NJ. The label emphasizes dispensing the medication guide to each patient and includes warnings and dosage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.